What foods should you avoid while taking cabergoline?
During taking cabergoline (Cabergoline), dietary management has a certain impact on drug absorption and efficacy. Cabergoline is a dopamine receptor agonist mainly used to treat prolactinemia and related pituitary tumors. Its oral absorption may be affected by food, especially high-fat meals. High-fat foods will reduce the drug absorption rate, thereby affecting blood drug concentration, which may lead to delayed or insufficient efficacy. Therefore, patients are advised to avoid high-fat meals before and after taking the drug.
Additionally, caution should be exercised with caffeinated and alcoholic beverages. Caffeine-containing beverages such as coffee and strong tea may aggravate the side effects of cabergoline such as mild decrease in blood pressure and heart palpitations, while alcohol may increase the adverse effects of the drug on the central nervous system, such as dizziness, drowsiness or nausea. To ensure medication safety, patients should avoid excessive consumption of caffeinated drinks and alcohol while taking medication.
Foods rich in tyrosine or dopamine precursors, such as certain cheeses, fermented foods, etc., may also have a certain impact on the effects of dopamine receptor agonists. Although generally mild, it may cause blood pressure fluctuations or gastrointestinal discomfort in sensitive patients. Therefore, patients should moderately control their food intake while taking the medication and pay attention to their own reactions.
Finally, during the medication period, you should maintain the principle of eating regularly, eating small amounts and eating frequently, and avoid fasting or overeating to reduce the occurrence of gastrointestinal discomfort. A reasonable diet not only helps the absorption and efficacy of cabergoline, but also reduces the risk of side effects such as dizziness and nausea. At the same time, patients can consult a doctor or pharmacist before taking medication to obtain personalized dietary guidance to ensure drug efficacy and safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)